177 related articles for article (PubMed ID: 37084069)
41. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
42. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-).
Xue Y; Han Y; Li T; Chen S; Zhang J; Pan J; Wu Y; Wang Y; Shen J
Acta Haematol; 2010; 123(1):55-8. PubMed ID: 19955712
[TBL] [Abstract][Full Text] [Related]
44. [A case of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome, complicated with disseminated M. abscessus infection].
Asai Y; Ouchi H; Ohosima T; Nakano R; Yamano Y; Inoshima I; Yamauchi T; Fukuyama S; Inoue H; Nakanishi Y
Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1120-5. PubMed ID: 20058690
[TBL] [Abstract][Full Text] [Related]
45. A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract][Full Text] [Related]
46. High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease.
Arimura K; Arima N; Matsushita K; Akimoto M; Park CY; Uozumi K; Tei C
J Clin Immunol; 2007 Mar; 27(2):145-51. PubMed ID: 17235688
[TBL] [Abstract][Full Text] [Related]
47. High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet's Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet's Disease Database and Comparison with the Literature.
Shen Y; Ma HF; Luo D; Cai JF; Zou J; Guan JL
Biomed Res Int; 2018; 2018():8535091. PubMed ID: 29854799
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.
Wesner N; Drevon L; Guedon A; Fraison JB; Terrier B; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Seksik P; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
Leuk Lymphoma; 2019 Jul; 60(7):1782-1788. PubMed ID: 30457024
[TBL] [Abstract][Full Text] [Related]
49. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
[TBL] [Abstract][Full Text] [Related]
50. GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.
Bruzzese A; Leardini D; Masetti R; Strocchio L; Girardi K; Algeri M; Del Baldo G; Locatelli F; Mastronuzzi A
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066218
[TBL] [Abstract][Full Text] [Related]
51. GATA2 deficiency.
Hsu AP; McReynolds LJ; Holland SM
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):104-9. PubMed ID: 25397911
[TBL] [Abstract][Full Text] [Related]
52. Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.
Tanaka-Kubota M; Shinozaki K; Miyamoto S; Yanagimachi M; Okano T; Mitsuiki N; Ueki M; Yamada M; Imai K; Takagi M; Agematsu K; Kanegane H; Morio T
Int J Hematol; 2018 May; 107(5):610-614. PubMed ID: 29185156
[TBL] [Abstract][Full Text] [Related]
53. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
54. Large-vessel thrombosis in intestinal Behçet's disease complicated with myelodysplastic syndrome and trisomy 8.
Chen HC; Chiu YM
World J Gastroenterol; 2012 Mar; 18(10):1137-40. PubMed ID: 22416191
[TBL] [Abstract][Full Text] [Related]
55. Late appearance of t(1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis.
Ando J; Tamayose K; Sugimoto K; Oshimi K
Cancer Genet Cytogenet; 2002 Nov; 139(1):14-7. PubMed ID: 12547151
[TBL] [Abstract][Full Text] [Related]
56. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
Zhang Z; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
[TBL] [Abstract][Full Text] [Related]
57. Treatment of Crohn's disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review.
Hu C; Lv L; Liu D; Huo J
Clin J Gastroenterol; 2014 Aug; 7(4):299-304. PubMed ID: 25132866
[TBL] [Abstract][Full Text] [Related]
58. Pediatric intestinal Behçet disease complicated by myeloid malignancies.
Kanamitsu K; Shimada A; Nishiuchi R; Shigemura T; Nakazawa Y; Koike K; Kodama Y; Shinkoda Y; Kawano Y; Yasui K; Sasaki K; Kajiwara R; Tsukahara H; Manabe A
Int J Hematol; 2017 Mar; 105(3):377-382. PubMed ID: 27848185
[TBL] [Abstract][Full Text] [Related]
59. The association of Behçet's disease with myelodysplastic syndrome in Japan: a review of the literature.
Tada Y; Koarada S; Haruta Y; Mitamura M; Ohta A; Nagasawa K
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S115-9. PubMed ID: 17067441
[TBL] [Abstract][Full Text] [Related]
60. Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.
Itonaga H; Kida M; Hamamura A; Uchida N; Ozawa Y; Fukuda T; Ueda Y; Kataoka K; Katayama Y; Ota S; Matsuoka KI; Kondo T; Eto T; Kanda J; Ichinohe T; Atsuta Y; Miyazaki Y; Ishiyama K
Hematol Oncol; 2022 Oct; 40(4):752-762. PubMed ID: 35299289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
